For the quarter ending 2026-03-31, MRNA made $389M in revenue. -$1,343M in net income. Net profit margin of -345.24%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 389 | 678 | 1,016 | 142 |
| Cost of sales | 955 | 452 | 207 | 119 |
| Research and development | 649 | 775 | 801 | 700 |
| Selling, general and administrative | 173 | 308 | 268 | 230 |
| Total operating expenses | 1,777 | 1,535 | 1,276 | 1,049 |
| Loss from operations | -1,388 | -857 | -260 | -907 |
| Interest income | 72 | 70 | 73 | 81 |
| Other expense, net | -18 | -12 | 0 | 8 |
| Loss before income taxes | -1,334 | -799 | -187 | -818 |
| Provision for income taxes | 9 | 27 | 13 | 7 |
| Net loss | -1,343 | -826 | -200 | -825 |
| Basic EPS | -3.4 | -2.107 | -0.51 | -2.13 |
| Diluted EPS | -3.4 | -2.107 | -0.51 | -2.13 |
| Basic Average Shares | 395,000,000 | 392,000,000 | 390,000,000 | 388,000,000 |
| Diluted Average Shares | 395,000,000 | 392,000,000 | 390,000,000 | 388,000,000 |
Moderna, Inc. (MRNA)
Moderna, Inc. (MRNA)